Arslan et al.; 202155 Arslan E., Demir S.C., Ozsurmeli M., Akcabay C. Perinatal outcomes and survival predictors of severe red-cell alloimmunization treated by intrauterine transfusion. J Obstet Gynaecol Res. 2021;47(8):2632-2640.
|
Retrospective |
Turkey |
2015-2019 |
42/87 |
Survival rate, foetal mortality & hydrops |
Deka et al.; 201566 Deka D., Dadhwal V., Sharma A.K., Shende U., Agarwal S., Agarwal R., Vanamail P. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization. Arch Gynecol Obstet. 2015;293(5):967-73.
|
Prospective |
India |
2011-2014 |
102/303 |
Survival rate, foetal mortality, PR complications & hydrops |
Johnstone-Ayliffe et al.; 20122727 Johnstone-Ayliffe C., Prior T., Ong C., Regan F., Kumar S. Early procedure-related complications of fetal blood sampling and intrauterine transfusion for fetal anemia. Acta Obstet Gynecol Scand. 2012;91(4):458-62.
|
Retrospective |
UK |
2003-2010 |
46/114 |
Survival rate, foetal mortality, PR complications |
Osanan et al.; 20112828 Osanan G.C., Silveira Reis Z.N., Apocalypse I.G., Lopes A.P., Pereira A.K., da Silva Ribeiro O.M., Vieira Cabral A.C. Predictive factors of perinatal mortality in transfused fetuses due to maternal alloimmunization: what really matters? J Matern Fetal Neonatal Med. 2012;25(8):1333-7.
|
Retrospective |
Brazil |
1999-2009 |
128/305 |
Survival rate, foetal mortality, PR complications |
Pasman et al.; 20151414 Pasman S.A., Claes L., Lewi L., Van Schoubroeck D., Debeer A., Emonds M., Geuten E., De Catte L., Devlieger R. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven. Facts Views Vis Obgyn. 2015;7(2):129-36.
|
Retrospective |
Belgium |
2000-2014 |
56/135 |
Survival rate, foetal mortality & PR complications |
Sainio et al.; 20151616 Sainio S., Nupponen I., Kuosmanen M., Aitokallio-Tallberg A., Ekholm E., Halmesmäki E., Orden M.R., Palo P., Raudaskoski T., Tekay A., Tuimala J., Uotila J., Stefanovic V. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study. Acta Obstet Gynecol Scand. 2015;94(4):383-90.
|
Retrospective |
Finland |
2003-2012 |
104/339 |
Survival rate foetal mortality & PR complications |
Şavkli et al.; 20192929 Şavkli A.O., Çetin B.A., Acar Z., Özköse Z., Behram M., Çaypinar S.S., Tayyar A. & Yüksel M.A. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation, J Obstet Gynaecol (Lahore), 2020;40:5, 649-653.
|
Retrospective |
Turkey |
2015-2018 |
42/110 |
Survival rate, foetal mortality, PR complications & hydrops |
Somerset et al.; 20063030 Somerset D.A., Moore A., Whittle M.J., Martin W., Kilby M.D. An audit of outcome in intravascular transfusions using the intrahepatic portion of the fetal umbilical vein compared to cordocentesis. Fetal Diagn Ther. 2006;21(3):272-6.
|
Cohort study |
UK |
1997-2004 |
67/221 |
Survival rate, foetal mortality & hydrops |
Tiblad et al.; 20113131 Tiblad E., Kublickas M., Ajne G., Bui T.H., Ek S., Karlsson A., Wikman A., Westgen M. Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther. 2011;30(4):266-73.
|
Retrospective |
Sweden |
1990-2010 |
85/284 |
Survival rate, foetal mortality & PR complications |
van Kamp et al.; 20041313 van Kamp I.L., Klumper F.J., Meerman R.H., Oepkes D., Scherjon S.A., Kanhai H.H. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand. 2004;83(8):731-7.
|
Retrospective |
The Netherlands |
1988-1999 |
210/593 |
Survival rate, foetal mortality, & hydrops |
van Kamp et al.; 20052121 Van Kamp I.L., Klumper F.J., Oepkes D., Meerman R.H., Scherjon S.A., Vandenbussche F.P., Kanhai H.H. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol. 2005;192(1):171-7.
|
Cohort study |
The Netherlands |
1988-2001 |
254/740 |
Survival rate, foetal mortality & PR complications |
Walsh et al.; 20131515 Walsh C.A., Russell N., McAuliffe F.M., Higgins S., Mahony R., Carroll S., McParland P. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):235-9.
|
Retrospective |
Ireland |
1996-2011 |
102/242 |
Survival rate, foetal mortality & PR complications |
Weisz et al.; 20081919 Weisz B., Rosenbaum O., Chayen B., Peltz R., Feldman B., Lipitz S. Outcome of severely anaemic fetuses treated by intrauterine transfusions. Arch Dis Child Fetal Neonatal Ed. 2009;94(3):201-4.
|
Retrospective |
Israel |
1996-2004 |
54/154 |
Survival rate & foetal mortality |
Yinon et al.; 201033 Yinon Y., Visser J., Kelly E.N., Windrim R., Amsalem H., Seaward P.G., Ryan G. Early intrauterine transfusion in severe red blood cell alloimmunization. Ultrasound Obstet Gynecol. 2010;36(5):601-6.
|
Retrospective |
Canada |
1992-2008 |
30/137 |
Survival rate, foetal mortality, PR complications & hydrops |
Zwiers et al.; 20173232 Zwiers C., Lindenburg I.T.M., Klumper F.J., de Haas M., Oepkes D., Van Kamp I.L. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017;50(2):180-186.
|
Retrospective |
The Netherlands |
1988-2015 |
334/937
|
Survival rate, foetal mortality & PR complications |